201614-00-8

Basic information

• Product Name: methyl 7-chloro-6-methoxy-benzothiophene-2-carboxylate
• Synonyms: methyl 7-chloro-6-methoxy-1-benzothiophene-2-carboxylate; Methyl-7-chlor-6-methoxy-1-benzothiophen-2-carboxylat
• CAS NO: 201614-00-8
• Molecular Formula: C₁₁H₉ClO₃S
• Molecular Weight: 256.71
• Mol File: 201614-00-8.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 374.4°C at 760 mmHg
• Flash Point: 180.3°C
• Density: 1.373g/cm³
• Vapor Pressure: 8.35E-06mmHg at 25°C
• Refractive Index: 1.622
• CAS DataBase Reference: methyl 7-chloro-6-methoxy-benzothiophene-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 7-chloro-6-methoxy-benzothiophene-2-carboxylate(201614-00-8)
• EPA Substance Registry System: methyl 7-chloro-6-methoxy-benzothiophene-2-carboxylate(201614-00-8)

Safety Data

• Hazardous Substances Data: 201614-00-8(Hazardous Substances Data)

Upstream product

• 2365-48-2 Methyl thioglycolate 
• 446-60-6 2-chloro-1-fluoro-3-methoxybenzene 

Relevant articles and documents

GEMINAL SUBSTITUTED QUINUCLIDINE AMIDE COMPOUNDS AS AGONISTS OF ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTORS

The present invention relates to novel geminal substituted quinuclidine amide compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of α7- nAChR, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.